Purinergic receptor regulation of LPS-induced signaling and pathophysiology

Abstract

Macrophages express several lipopolysaccharide (LPS) binding proteins and are potently activated by LPS to produce inflammatory mediators. Recent studies have shown that receptors for exogenous nucleotides (P2X and P2Y purinergic receptors) can modulate macrophage production of TNF-α , IL-1β and nitric oxide (NO) following LPS exposure. Macrophages and LPS-stimulated monocytes express elevated levels of P2Y₁, P2Y₂ and P2X₇ mRNA, suggesting that both P2Y and P2X receptors can contribute to LPS-induced pathophysiology. In addition, oxidized-ATP treatment (which inhibits P2X₇) of macrophages blocks LPS-induced NO production, NF-κB and ERK-1/2 activation. Also, an LPS-binding domain located in the P2X₇ C-terminus appears important for receptor trafficking/function. Moreover, the purinergic receptor ligand 2-MeS-ATP attenuates LPS-induced cytokine and NO production in vivo and ex vivo. These data suggest that P2X₇ and certain P2Ys are linked to LPS effects, although their relative contribution in vivo is unclear. Accordingly, we tested the capacity of several adenine nucleotides to modulate LPS-induced mortality in mice. We found that the P2X₇-directed ligand BzATP was unable to prevent LPS-induced death, whereas 2-MeS-ATP and 2-Cl-ATP, which bind to multiple P2X and P2Y receptors were able to protect mice from LPS-induced death. These data suggest that the co-ordinate action of P2Y and P2X₇ receptors are critical for controlling LPS responses in vivo and that agents directed against both receptor classes may provide the greatest therapeutic advantage.

References

Abraham E. , Matthay MA , Dinarello CA et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation . Crit Care Med 2000; 28: 232-235.

Bellingan G. Inflammatory cell activation in sepsis. Br Med Bull 1999; 55: 12-29.

Denlinger LC , Proctor RA Potential risk factors for developing apoptosis during septic shock. Crit Care Med 2000; 28: 2133-2134.

Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 2000; 12: 20-26.

Denlinger LC , Fisette PL , Sommer JA et al. The nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol 2001; 167: 1871-1876.

Tanke T. , van de Loo JW , Rhim H. , Leventhal PS , Proctor RA , Bertics PJ Bacterial lipopolysacch aride-stimulated GTPase activity in RAW 264.7 macrophage membranes. Biochem J 1991; 277: 379-385.

Proctor RA , Denlinger LC , Leventhal PS et al. Protection of mice from endotoxic death by 2-methylthio-ATP . Proc Natl Acad Sci USA 1994; 91: 6017-6020.

Di Virgilio F , Chiozzi P. , Ferrari D. et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001; 97: 587-600.

Watters JJ , Sommer JA , Fisette PL et al. The P2X7 nucleotide receptor: modulation of LPS-induced macrophage signaling and mediator production. Drug Dev Res 2001; 53: 91-104.

10.

Sak K. , Webb TE A retrospective of recombinant P2Y receptor subtypes and their pharmacology . Arch Biochem Biophys 2002; 397: 131-136.

11.

Khakh BS , Burnstock G. , Kennedy C. et al. International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 2001; 53: 107-118.

12.

Dubyak GR , Clifford EE , Humphreys BD , Kertesy SB , Martin KA Expression of multiple ATP receptor subtypes during the differentiation and inflammatory activation of myeloid leukocytes. Drug Dev Res 1996; 39: 269-278.

13.

Burnstock G. Overview of P2 receptors: possible functions in immune cells. Drug Dev Res 2001; 53: 53-59.

14.

Hu Y. , Fisette PL , Denlinger LC et al. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem 1998; 273: 27170-27175.

15.

Denlinger LC , Fisette PL , Garis KA et al. Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem 1996; 271: 337-342.

16.

Sommer JA , Fisette PL , Hu Y. et al. Purinergic receptor modulation of LPS-stimulated signaling events and nitric oxide release in RAW 264.7 macrophages. J Endotoxin Res 1999; 5: 70-74

17.

Sikora A. , Liu J. , Brosnan C. , Buell G. , Chessel I. , Bloom BR Purinergic signaling regulates radical-mediate bacterial killing mechanisms in macrophages through a P2X7-independent mechanism. J Immunol 1999; 163: 558-561.

18.

Fisette P. Role of the P2X7 nucleotide receptor in lipopolysaccharide-stimulatedmacrophage activation. PhD Thesis, 1999; University of Wisconsin-Madison, USA.

19.

Boarder MR , Hourani SMO The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol Sci 1998; 19: 99-107.

20.

Warny M. , Aboudola S. , Robson SC et al. P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem 2001; 276: 26051-26056.

21.

Perregaux DG , McNiff P. , Laliberte R. , Conklyn M. , Gabel CA ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J Immunol 2000; 165: 4615-4623.

22.

Solle M. , Labasi J. , Perregaux DG et al. Altered cytokine production in mice lacking P2X(7) receptors . J Biol Chem 2001; 276: 125-132.